Bmx tyrosine kinase transgene induces skin hyperplasia, inflammatory angiogenesis, and accelerated wound healing

Molecular Biology of the Cell

Volumn 15, Issue 9, 2004, Pages 4226-4233

  Paavonen, Karri ^a   Ekman, Niklas ^a   Wirzenius, Maria ^a   Rajantie, Iiro ^a   Poutanen, Matti ^b   Alitalo, Kari ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BMX GENE; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIZATION; FIBROSARCOMA; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KERATINOCYTE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CARCINOGENESIS; TRANSGENE; WOUND HEALING;

ANIMALS; BASE SEQUENCE; CELL DIFFERENTIATION; DNA; GENE EXPRESSION; HUMANS; HYPERPLASIA; INFLAMMATION MEDIATORS; KERATIN-14; KERATINOCYTES; KERATINS; MICE; MICE, TRANSGENIC; NEOVASCULARIZATION, PATHOLOGIC; PROMOTER REGIONS (GENETICS); PROTEIN-TYROSINE KINASES; SKIN; WOUND HEALING;

ANIMALIA; MUS MUSCULUS;

EID: 4344568204     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E04-03-0241     Document Type: Article

References (39)

1. Abassi, Y.A., Rehn, M., Ekman, N., Alitalo, K., and Vuori, K. (2003). p130Cas couples the tyrosine kinase Bmx/Etk with regulation of the actin cytoskeleton and cell migration. J. Biol. Chem. 278, 35636-35643.
2. Bagheri-Yarmand, R., Mandal, M., Taludker, A.H., Wang, R.A., Vadlamudi, R.K., Kung, H.J., and Kumar, R. (2001). Etk/Bmx tyrosine kinase activates Pak1 and regulates tumorigenicity of breast cancer cells. J. Biol. Chem. 276, 29403-29409.
3. Belperio, J.A., Keane, M.P., Arenberg, D.A., Addison, C.L., Ehlert, J.E., Burdick, M.D., and Strieter, R.M. (2000). CXC chemokines in angiogenesis. J. Leukoc. Biol. 68, 1-8.
4. Breitenbach, U., Tuckermann, J.P., Bebhardt, C., Richter, K.H., Furstenberger, G., Christofori, G., and Angel, P. (2001). Keratinocyte-specific onset of serine protease BSSP expression in experimental carcinogenesis. J. Invest. Dermatol. 117, 634-640.
5. Chau, C.H., Chen, K.Y., Deng, H.T., Kim, K.J., Hosoya, K., Terasaki, T., Shih, H.M., and Ann, D.K. (2002). Coordinating Etk/Bmx activation and VEGF upregulation to promote cell survival and proliferation. Oncogene 21, 8817-8829.
6. Chen, R., Kim, O., Li, M., Xiong, X., Guan, J.L., Kung, H.J., Chen, H., Shimizu, Y., and Qiu, Y. (2001). Regulation of the PH-domain-containing tyrosine kinase Etk by focal adhesion kinase through the FERM domain. Nat. Cell Biol. 3, 439-444.
7. Chu, P.G., and Weiss, L.M. (2002). Keratin expression in human tissues and neoplasms. Histopathology 40, 403-439.
8. Ekman, N., Arighi, E., Rajantie, I., Saharinen, P., Ristimaki, A., Silvennoinen, O., and Alitalo, K. (2000). The Bmx tyrosine kinase is activated by IL-3 and G-CSF in a PI-3K dependent manner. Oncogene 19, 4151-4158.
9. Ekman, N., Lymboussaki, A., Vastrik, I., Sarvas, K., Kaipainen, A., and Alitalo, K. (1997). Bmx tyrosine kinase is specifically expressed in the endocardium and the endothelium of large arteries. Circulation 96, 1729-1732.
10. Ellmeier, W., Jung, S., Sunshine, M.J., Hatam, F., Xu, Y., Baltimore, D., Mano, H., and Littman, D.R. (2000). Severe B cell deficiency in mice lacking the tec kinase family members Tec and Btk. J. Exp. med. 192, 1611-1624.
11. Epstein, F.H. (1998). Chemokines-chemotactic cytokines that mediate inflammation. New Engl. J. Med. 338, 436-445.
12. Fruman, D.A., Satterthwaite, A.B., and Witte, O.N. (2000). Xid-like phenotypes: a B cell signalosome takes shape. Immunity 13, 1-3.
13. Gutierrez, L.S., Schulman, A., Brito-Robinson, T., Noria, F., Ploplis, V.A., and Castellino, F.J. (2000). Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1. Cancer Res. 60, 5839-5847.
14. Hamm-Alvarez, S.F., Chang, A., Wang, Y., Jerdeva, G., Lin, H.H., Kim, K.J., and Ann, D.K. (2001). Etk/Bmx activation modulates barrier function in epithelial cells. Am. J. Physiol. Cell Physiol. 280, C1657-C1668.
15. Honda, H., Mano, H., Katsuki, M., Yazaki, Y., and Hirai, H. (1995). Increased tyrosine-phophorylation of 55KDa proteins in beta-actin/Tec transgenic mice. Biochem. Biophys. Res. Commun. 206, 287-293.
16. Kaukonen, J., Lahtinen, I., Laine, S., Alitalo, K., and Palotie, A. (1996). BMX tyrosine kinase gene is expressed in granulocytes and myeloid leukaemias. Br. J. Haematol. 94, 455-460.
17. Liao, X.C., and Littman, D.R. (1995). Altered T cell receptor signaling and disrupted T cell development in mice lacking Itk. Immunity 3, 757-769.
18. Mano, H. (1999). Tec family of protein-tyrosine kinases: an overview of their structure and function. Cytokine Growth Factor 10, 267-280.
19. Morganstern, J.P., and Land, H. (1990). Advanced mammalian gene transfer: high titer retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18, 3587-3596.
20. Pan, S., An, P., Zhang, R., He, X.R., Yin, G.Y., and Min, W. (2002). Etk/Bmx as a tumor necrosis factor receptor type 2-specific kinase: role in endothelial cell migration and angiogenesis. Mol. Cell. Biol. 22, 7512-7523.
21. Petrova, T.V. et al. (2002). Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. EMBO J. 21, 4593-4599.
22. Qiu, Y., and Kung, H.J. (2000). Signaling network of the Btk family kinases. Oncogene 19, 5651-5661.
23. Qiu, Y., Robinson, D., Pretlow, T., and Kung, H. (1998). Etk/Bmx, a tyrosine kinase with pleckstrin-homology domain, is an effector of phosphatidylinositol 3′-kinase and is involved in interleukin 6-induced neuroendocrine differentiation of prostate cancer cells. Proc. Natl. Acad. Sci. USA 95, 3644-3649.
24. Rajantie, I., Ekman, N., Iljin, K., Arighi, E., Gunji, Y., Kaukonen, J., Palotie, A., Dewerchin, M., Carmeliet, P., and Alitalo, K. (2001). Bmx tyrosine kinase has a redundant function downstream of angiopoietin and vascular endothelial growth factor receptors in arterial endothelium. Mol. Cell. Biol. 21, 4647-4655.
25. Rapp, U.R., Keski-Oja, J., and Heine, U.I. (1979). Establishment and characterization of the epithelial mouse embryo cell line MMC-E. Cancer Res. 39, 4111-4118.
26. Robinson, D., He, F., Pretlow, T., and Kung, H.J. (1996). A tyrosine kinase profile of prostate carcinoma. Proc. Nat. Acad. Sci. USA 93, 5958-5962.
27. Saaristo, A. et al. (2002). Adenoviral VEGF-C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes. FASEB J. 16, 1041-1049.
28. Satterthwaite, A.B., and Witte, O.N. (2000). The role of Bruton's tyrosine kinase in B-cell development and function: a genetic perspective. Immunol. Rev. 175, 120-127.
29. Schaeffer, E.M. et al. (1999). Requirement for Tec kinases Rlk and Itk in T cell receptor signaling and immunity. Science 284, 638-641.
30. Smith, C.I., Islam, T.C., Mattsson, P.T., Mohamed, A.J., Nore, B.F., and Vihinen, M. (2001). The Tec family of cytoplasmic tyrosine kinases: mammalian Btk, Bmx, Itk, Tec, Txk and homologs in other species. Bioessays 23, 436-446.
31. Sommers, C.L., Rabin, R.L., Grinberg, A., Tsay, H.C., Farber, J., and Love, P.E. (1999). A role for the Tec family tyrosine kinase Txk in T cell activation and thymocyte selection. J. Exp. Med. 190, 1427-1438.
32. Sternlicht, M.D., Bissell, M.J., and Werb, Z. (2000). The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter. Oncogene 19, 1102-1113.
33. Tamagnone, L. et al. (1994). BMX, a novel nonreceptor tyrosine kinase gene of the BTK/ITK/TEC/TXK family located in chromosome Xp22.2. Oncogene 9, 3683-3688.
34. Tesfaigzi, J., and Carlson, D.M. (1999). Expression, regulation, and function of the SPR family of proteins. A review. Cell. Biochem. Biophys. 30, 243-265.
35. Vassar, R., Rosenberg, M., Ross, S., Tyner, A., and Fuchs, E. (1989). Tissue-specific and differentiation-specific expression of a human K14 keratin gene in transgenic mice. Proc. Natl. Acad. Sci. USA 86, 1563-1567.
36. Weil, D., Power, M.A., Smith, S.I., and Li, C.L. (1997). Predominant expression of murine Bmx tyrosine kinase in the granulo-monocytic lineage. Blood 90, 4332-4340.
37. Werner, S., Werner, S., and Munz, B. (2000). Suppression of keratin 15 expression by transforming growth factor beta in vitro and by cutaneous injury in vivo. Exp. Cell Res. 254, 80-90.
38. Xue, L.Y., Qiu, Y., He, J., Kung, H.J., and Oleinick, N.L. (1999). Etk/Bmx, a PH-domain containing tyrosine kinase, protects prostate cancer cells from apoptosis induced by photodynamic therapy or thapsigargin. Oncogene 18, 3391-3398.
39. Zhang, R., Xu, Y., Ekman, N., Wu, Z., Wu, J., Alitalo, K., and Min, W. (2003). Etk/Bmx transactivates vascular endothelial growth factor 2 and recruits phosphatidylinositol 3-kinase to mediate the tumor necrosis factor-induced angiogenic pathway. J. Biol. Chem. 278, 51267-51276.